1.490USD-2.61%Mkt Cap: 462.80M $P/E: —1d ago
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single mol…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap462.80M $
Enterprise Value905.65M $
Revenue (TTM)160.03M $
Gross Profit45.78M $
Net Income (TTM)-546.38M $
Revenue/Share0.5300 USD
Last Price1.490 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees485
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS69404D1081
Valuation
P/E (Trailing)—
P/E (Forward)-3.76
PEG—
EV/EBITDA-6.33
EV/Revenue5.66
P/S2.89
P/B186.25
EPS (TTM)-0.41
EPS (Forward)-0.40
52W Range
1.09024% of range2.730
52W High2.730 USD
52W Low1.090 USD
Profitability
Gross Margin28.61%
Oper. Margin-102.89%
EBITDA Margin-89.45%
Profit Margin-341.47%
ROE-10214.54%
ROA-69.68%
Growth
Revenue Growth0.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-111.21M $
CapEx (TTM)7.71M $
FCF Margin-30.14%
FCF Yield-10.42%
Net Debt430.43M $
Net Debt/EBITDA-3.01
Balance Sheet
Debt/Equity131.32
Current Ratio5.65
Quick Ratio4.67
Book Value/Sh0.0080 USD
Cash/Share0.8880 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2.458 USD
Upside (mean)+65.0%
Target Range1.500 USD – 3.000 USD
$1.500+65.0% to mean$3.000
# Analysts6
Ownership
Shares Out.310.60M
Float303.83M
Insiders8.77%
Institutions53.81%
Short Interest
Short Ratio7.2d
Short % Float17.58%
Short % Out.15.29%
Shares Short47.49M
Short (prev mo.)48.71M
Technical
SMA 501.444 (+3.2%)
SMA 2001.709 (-12.8%)
Beta2.29
S&P 52W Chg20.25%
Avg Vol (30d)5.72M
Avg Vol (10d)4.66M
Technical Indicators
RSI (14)48.1
MACD0.0258
MACD Signal0.0423
MACD Hist.-0.0165
BB Upper1.809 USD
BB Middle1.532 USD
BB Lower1.255 USD
BB Width36.12%
ATR (14)0.1166 USD
Vol Ratio (20d)0.73x